Radiotherapy
Radiotherapy fails to extend DFS after complete resection in NSCLC
Radiotherapy after complete resection and neoadjuvant chemotherapy failed to significantly improve 3-year DFS among certain patients with non-small cell lung cancer, according to study results presented during ESMO Virtual Congress 2020.
FDA grants orphan drug designation to novel glioblastoma treatment
The FDA granted orphan drug designation to rhenium nanoliposomes for the treatment of patients with recurrent glioblastoma, according to a manufacturer-issued press release.
Radiotherapy for certain childhood cancers linked to long-term cardiometabolic effects
Adults who received radiation therapy during childhood for abdominal and pelvic cancers appeared more likely than the general population to experience body composition abnormalities and worse cardiometabolic outcomes, study results showed.
Shorter radiotherapy regimen shows long-term safety, efficacy in early breast cancer
Adjuvant whole-breast radiotherapy delivered in a five-fraction, once-weekly schedule appeared safe and effective for women with early breast cancer, according to 10-year results of the FAST trial published in Journal of Clinical Oncology.
ASTRO elects four new officers
Members of the American Society for Radiation Oncology elected four new officers to the organization’s board of directors.
Addition of radiotherapy to chemotherapy extends OS in metastatic nasopharyngeal carcinoma
Radiotherapy in combination with chemotherapy significantly improved OS among chemotherapy-sensitive patients with metastatic nasopharyngeal carcinoma, according to results of a randomized phase 3 study published in JAMA Oncology.
Researchers look to radiotherapy to treat severe cases of COVID-19
Several trials exploring radiation’s potential as a treatment for critically ill patients with COVID-19 are underway in the United States.
Most Graves’ disease treated with antithyroid drugs
Adults with Graves’ disease are more likely to receive drug treatment — despite a higher failure rate — than radioactive iodine therapy or thyroid surgery, according to findings published in Thyroid.
VIDEO: Advantages of aggressive therapy for metastatic EGFR-mutated NSCLC
In this video, Julia K. Rotow, MD, medical oncologist at Dana-Farber Cancer Institute, discussed high-dose hypofractionated radiotherapy in combination with tyrosine kinase inhibitors for the treatment of EGFR-mutated non-small cell lung cancer with limited metastatic disease.
COVID-19 pandemic prompts emergency radiation therapy guidelines for hematologic malignancies
An International Lymphoma Radiation Oncology Group task force has developed emergency recommendations for the management of radiation therapy for patients with hematologic malignancies during the COVID-19 pandemic.